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Abstract The objective of this paper was to study cancer
incidence, especially leukemia in children (\15 years), in
the vicinity of Finnish nuclear power plants (NPPs). We
used three different approaches: ecological analysis at
municipality level, residential cohorts deﬁned from census
data, and case–control analysis with individual residential
histories. The standardized incidence ratio of childhood
leukemia for the seven municipalities in the vicinity of
NPPs was 1.0 (95% CI 0.6, 1.6) compared to the rest of
Finland. The two cohorts deﬁned by censuses of 1980 and
1990 gave rate ratios of 1.0 (95% CI 0.3, 2.6) and 0.9 (95%
CI 0.2, 2.7), respectively, for childhood leukemia in the
population residing within 15 km from the NPPs compared
to the 15–50 km zone. The case–control analysis with 16
cases of childhood leukemia and 64 matched population-
based controls gave an odds ratio for average distance
between residence and NPP in the closest 5–9.9 km zone of
0.7 (95% CI 0.1, 10.4) compared to C30 km zone. Our
results do not indicate an increase in childhood leukemia
and other cancers in the vicinity of Finnish NPPs though
the small sample size limits the strength of conclusions.
The conclusion was the same for adults.
Keywords Cancer incidence  Nuclear power 
Childhood leukemia
Introduction
An increased incidence of childhood cancer, especially
leukemia, in the vicinity of nuclear installations was ﬁrst
suggested near Sellaﬁed by a TV broadcast in 1983 [1].
Since then, several studies have investigated childhood
leukemia and other cancers in the proximity of nuclear
facilities, involved in nuclear power production, repro-
cessing, or fuel processing, with inconclusive results [2–8],
for example. A recent German study reported an increased
risk of leukemia and overall cancer among children aged
less than 5 years living within the 5-km zone around power
plants [9, 10].
We investigated the incidence of leukemia and overall
cancer among children and adults in the vicinity of the
two Finnish nuclear power plants (NPPs) to contribute to
the evidence about cancer and nuclear facilities with three
alternative approaches: ecological analysis, residential
cohorts, and case–control analysis with individual resi-
dential histories. We also conducted an ecological anal-
ysis of leukemia and overall cancer incidence near a
potential new NPP [11, 12] planned in three alternative
sites.
Materials and methods
Four nuclear power reactors have been in production in
Finland since the late 1970s. The two NPPs both have two
reactors and are located in the Southern (Loviisa) and
southwestern Finland (Olkiluoto) (Fig. 1). The NPP in
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Olkiluoto in October 1979. The ﬁfth Finnish nuclear power
reactor is currently under construction in Olkiluoto and is
expected to be in production in 2012. Furthermore, discus-
sions on a possible new site for the next NPP have begun.
We deﬁned municipalities in the vicinity of a NPP as
those with any area within 15 km from a NPP. Distance
was calculated from the midpoint of the two reactors in
both nuclear sites. Four municipalities fulﬁlled these cri-
teria in the Loviisa region (Loviisa, Ruotsinpyhta ¨a ¨, Per-
naja, and Pyhta ¨a ¨) and three in the Eurajoki region
(Eurajoki, Luvia, and Rauma) (Fig. 1).
We studied leukemia and cancer incidence both among
children and adults but with an emphasis on children in
ages 0–14 years. Adult population refers to all people aged
at least 15 years.
Ecological analysis
We ﬁrst compared leukemia and overall cancer incidence
between the municipalities adjacent to the NPPs (Fig. 1)
and the rest of Finland using ecological analysis with
municipality-level data. Numbers of leukemia and overall
cancer cases and population counts were obtained from the
Finnish Cancer Registry by 5-year age group, sex, and
calendar year (1975–2004). The municipalities adjacent to
the Olkiluoto plant had more than twice the population size
of those around Loviisa. The number of children was
roughly a ﬁfth of the adults (Table 1).
We estimated standardized incidence ratios (SIRs) by
relating the observed numbers of cancer cases to the
expected ones by time prior to and since the production
started in the NPPs. The expected numbers were based on
stratum-speciﬁc incidence in the rest of Finland. Period
prior to the production was years 1975–77 for Loviisa and
years 1975–79 for Olkiluoto. We analyzed SIRs to evaluate
possible changes by age group, sex, and time since the
production with the Poisson regression using Stata statis-
tical software (version 10, Stata Corp., College Station,
TX).
We used ecological municipality-level analysis also to
compare leukemia and overall cancer incidence between
Fig. 1 Current and planned NPP sites (large graph). NPPs, Loviisa
and Olkiluoto, are located at seashore in the Southern and
southwestern Finland, respectively. New NPP are planned to be
located in new sites, possibly either in Kristiinankaupunki, Pyha ¨joki,
or Simo. Municipalities adjacent to NPPs Loviisa and Olkiluoto with
0–15 km (\15 km) and 15–50 km (C15 and \50 km) residential
zones (small graphs): Ecological and case–control analyses cover
gray area, and residential zones were used in cohort analysis. Source:
Municipal boundaries  National Land Survey of Finland, licence 53/
MML/09
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NPP sites and the rest of Finland. Municipalities with any
area within 15 km from three potential NPPs (Kris-
tiinankaupunki, Simo, and Pyha ¨joki) were regarded adja-
cent to planned NPPs (Fig. 1). One municipality fulﬁlled
this criteria in each site (Merikarvia was adjacent to Kris-
tiinankaupunki, Kemi to Simo, and Raahe to Pyha ¨joki).
Cohort analysis
Residential cohorts of people living near NPPs were
formed based on census data. For the cohorts of 1980 and
1990, the coordinates of residence in 31 December 1980
and 31 December 1990, respectively, were obtained from
the Population Register Center. The cohorts of 1980 and
1990 were followed up from 1 January 1981 to 31
December 2000 and from 1 January 1991 to 31 December
2000, respectively. Cancer cases diagnosed during the
follow-up of the cohort were obtained from the Finnish
Cancer Registry. Data on population counts and cancer
cases by sex, 5-year group of attained age, and socioeco-
nomic status were aggregated into 2 km 9 2 km squares
based on coordinates of the residences in the beginning of
both follow-up periods. The location of each 2 km 9 2k m
square was determined by its midpoint.
Leukemia and overall cancer incidence in cohorts living
within 15 km radius (\15 km) around the NPPs were
compared to the reference group living in the 15–50-km
zone (C15 and\50 km) (Fig. 1). We calculated the indi-
rectly standardized risk ratios (RRs) adjusting for age and
socioeconomic status and present them for children and
adults by sex. We used the Rapid Inquiry Facility (RIF)
software, which is a rapid tool for analyzing routinely
collected health data in relation to environmental exposures
[13]. The RIF is a functional extension of ArcGIS version 9
geographical information system (Environmental Systems
Research Institute Inc., Redlands, CA, USA).
Case–control analysis
Case–control analysis with matched controls was con-
ducted for leukemia only. Leukemia cases (C91-95 in ICD
10) diagnosed between 1 January 1977 and 31 December
2004 and living in the municipalities adjacent to the NPPs
at the time of diagnosis were identiﬁed from the Finnish
Cancer Registry. Four controls were randomly chosen from
the Population Register Center and were individually
matched to the cases with respect to sex, age, and the
municipality of residence at index date i.e., the date of
diagnosis of the corresponding case. Residential histories
of all study subjects were obtained from the Population
Register Center. Information on history of radiation work
at a NPP was retrieved for subjects’ parents (for children)
or subjects themselves (for adults) from the occupational
exposure registry maintained by the Radiation and Nuclear
Safety Authority (STUK), the governmental radiation
protection agency.
The case–control data included originally 17 children
(aged\15 years). By restricting to children who had been
diagnosed after the commercial production of the closest
Table 1 Mean population sizes in the municipalities adjacent to nuclear power plants (NPPs) for children (aged\15 years) and adults (aged
C15 years) by the NPP (Loviisa or Olkiluoto), sex, and 5-year calendar period
Children Loviisa Olkiluoto Loviisa and Olkiluoto
Boys Girls Boys Girls Boys Girls
1975–79 2,190 2,130 5,510 5,420 7,690 7,540
1980–84 2,100 1,970 5,280 5,180 7,380 7,160
1985–89 1,980 1,880 4,950 4,820 6,930 6,700
1990–94 1,910 1,820 4,500 4,410 6,410 6,230
1995–99 1,760 1,750 4,180 4,100 5,940 5,860
2000–04 1,640 1,630 3,810 3,720 5,450 5,350
Adults Loviisa Olkiluoto Loviisa and Olkiluoto
Men Women Men Women Men Women
1975–79 8,290 8,660 17,640 18,480 25,930 27,130
1980–84 8,440 8,810 18,540 19,520 26,980 28,320
1985–89 8,420 8,693 18,810 20,030 27,220 28,720
1990–94 8,400 8,610 18,860 20,110 27,260 28,720
1995–99 8,210 8,280 18,910 20,010 27,120 28,290
2000–04 8,070 8,110 18,750 19,770 26,820 27,880
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123NPP, 16 cases with 64 matched controls were eligible. Of
them, 8 were diagnosed in Loviisa and 8 in Olkiluoto area,
11 (69%) were boys and 5 (31%) girls, and four boys and
four girls were less than 5 years at diagnosis. All childhood
cases had acute lymphoblastic leukemia. After the exclu-
sion of adult cases with chronic lymphocytic leukemia
(n = 64) and their controls (n = 256), case–control anal-
ysis included 104 adults (aged C15 years) leukemia cases
with 420 matched controls.
Residential history data included the coordinates of
residence and moving dates with some missing residential
coordinates. In children, the coordinates of residential
history were missing for 8% (3/38 coordinates) of cases
and 4% (5/128 coordinates) of controls, and in adults, the
corresponding percentages were 6% (12/196) and 11% (89/
828), respectively. If the coordinates were missing and a
subject was aged less than 20 years, he/she was assumed to
have lived next to a main church in a municipality he/she
was born. If a subject was at least 20 years, he/she was
assumed to have lived next to a main church in the
municipality of residence at the index date. At the time of
index date, the coordinates were missing in children for
one (6%) case and one (2%) control, and in adults for 8
(8%) cases and 24 (6%) controls.
Residential history was constructed for the period
starting from the date of production of the adjacent NPP
until the index date. The distances from the adjacent NPP
to each residence and corresponding durations were cal-
culated for each subject. Average distance was calculated
as the sum of distances weighted by their relative dura-
tions, and it included the period starting from the start-up
of the closest NPP or birth date (whichever was later) until
the index date. We used this average distance (in meters) as
the primary distance measure, and the distance at the index
date and the minimum distance (i.e., shortest distance from
any of the subject’s residences to the NPP) as secondary
distance measures.
One of the parents of 14 children, 3 (19%) cases and 11
(17%) controls, had a history of radiation work under
dosimetric surveillance at a NPP before the index date. For
adults, a personal history of radiation work at NPP was
taken into account (13 subjects, 3 (3%) cases, and 10 (2%)
controls).
One 3-year-old case and two adults (controls) were
excluded from the analysis of continuous average distance
due to exceptionally high values. For this child, the average
distance was 172.0 km and for the adults, 154.5 and
376.3 km.
We estimated odds ratios (ORs) using conditional
logistic regression in Stata. The primary analysis included
children with average distance as an explanatory variable,
additionally adjusting for parents’ radiation work (yes/no)
and father’s age at child’s birth (numerical). Both
categorical distances (0–4, 5–9, 10–19, 20–29, C30 km
with trend tests) and continuous distances were used as
explanatory variables in the analyses. We analyzed the data
also for adults, and by two histological types of leukemia
(acute lymphoblastic leukemia and other histological types
combined). We tested the heterogeneity of ORs between
NPP sites, sexes, calendar period (1977–85, 1986–94,
1995–2004), histological types (acute lymphoblastic leu-
kemia and others), and age groups with the likelihood ratio
test. We also compared the numbers of residencies between
cases and controls using Fisher’s exact test and conditional
logistic regression.
Ethical approval
The study was based on registry data only, and study
persons were not contacted by the researchers. The ethics
of the study protocol was reviewed by the Finnish Advisory
Committee on Radiation Safety.
Results
Ecological analysis
Incidence of childhood leukemia and overall cancer in the
seven municipalities surrounding the two nuclear power
sites was low prior to start of nuclear energy production
with SIR = 0.34 (95% CI 0.01, 1.91), with one observed
leukemia case versus 2.9 expected (Table 2). During the
NPP operations, incidence was comparable to the rest of
the country as SIR = 1.01 (95% CI 0.58, 1.64), with a total
16 leukemia cases observed versus 15.9 expected.
In adults, leukemia and overall cancer incidence were
comparable to national average both in the period pre-
ceding and during the NPP operations for men and women.
During the NPP operations, 170 adult leukemia cases were
observed versus 158.1 expected with SIR = 1.08 (95% CI
0.92, 1.25). Number of overall observed cancer cases was
6,818 versus 6,941.2 expected with SIR = 0.98 (0.96,
1.01).
Leukemia and overall cancer incidence in the munici-
palities adjacent to planned NPPs in new sites were gen-
erally comparable to that in the rest of Finland both in
children and adults. In children, 16 leukemia cases were
observed versus 18.9 expected with SIR = 0.85 (95% CI
(0.48, 1.37), and 58 overall cancer cases versus 60.7
expected with SIR = 0.96 (95% CI 0.73, 1.24) in 1975–
2004. For adults in the same period, 180 leukemia cases
were observed versus 163.1 expected (SIR = 1.10 with
95% CI (0.95, 1.28)). In adults, however, overall cancer
incidence was higher in the vicinity of planned NPPs than
in the rest of Finland with 7,460 cases were observed
590 Cancer Causes Control (2010) 21:587–595
123versus 6,957.5 expected (SIR = 1.07 with 95% CI (1.05,
1.10)).
Cohort analysis
In children, the rate ratio (RR) of leukemia for the residents
in the 15-km zone surrounding the NPPs was 1.03 (95% CI
0.28, 2.63) for both sexes combined for the 1980 cohort
(four cases) and 0.91 (95% CI 0.19, 2.65) for the 1990
cohort (three cases, Table 3). The overall cancer incidence
within the 15-km inner zone from the NPPs was compa-
rable to that in the 15–50-km zone. The RR stratiﬁed by
10-year calendar period and nuclear power site was, how-
ever, slightly increased in overall cancer among boys for
the 1980 cohort around Loviisa site during 1981–1990 (ﬁve
cases, RR = 3.19, 95% CI 1.04, 7.45).
In adults, leukemia and overall cancer incidence for the
residents within the 15-km inner zone from the NPPs were
comparable to that in the 15–50-km zone for the both
cohorts (Table 3).
Case–control analysis
For childhood leukemia, the mean of average distance was
18.4 km for cases and 19.3 km for controls, and the corre-
sponding median was 13.6 km for cases and 14.3 km for
controls.Themaximumofaveragedistancewas59.7 kmfor
cases and 86.4 km for controls. Only one child case and ﬁve
controls had average distances in the closest category
5–9.9 km with OR of 0.71 (95% CI 0.05, 10.43), compared
withthereference,C30-kmzone(Table 4).NoneoftheORs
differed signiﬁcantly from unity, and adjustment for the
covariates did not affect the ORs for primary distance
measure (average distance) or secondary distance measures
(distance at index date and minimum distance). There was
little indication of heterogeneity in the ORs between NPPs
(p = 0.81), sexes (p = 0.43),5-year agegroups (p = 0.26),
and calendar periods (p = 0.29) in the primary distance
measure, nor in the secondary distance measures.
Average distance as continuous variable was not asso-
ciated with childhood leukemia (OR 0.99 per km, 95% CI
0.95, 1.04). Adjustment for parental radiation work and
father’s age at child’s birth did not change the OR. The OR
for the secondary indicators was 1.20 per km (95% CI 0.94,
1.55) for distance at index date and 1.05 per km (95% CI
0.86, 1.30) for the minimum distance. We observed no
heterogeneity in the ORs between NPP sites, sexes, age
group, and calendar time periods in the primary distance
measure, nor generally in the secondary distance measures.
However, the ORs for distance at index date differed
between age groups (p = 0.05) and calendar periods
(p = 0.03) and the OR for minimum distance with calendar
periods (p = 0.03), but none of the stratiﬁed ORs indicated
an inverse relation to distance.
For adult leukemia cases, the mean of average distance
was 17.2 km and 17.4 km for controls. The corresponding
Table 2 Observed (Obs) and expected (Exp) numbers of childhood leukemia and overall cancer cases with standardized incidence ratios (SIRs)
and 95% conﬁdence intervals (95% CIs) in the municipalities adjacent to the NPPs
Time since Boys Girls Total
Start (y) Obs Exp SIR (95% CI) Obs Exp SIR (95% CI) SIR (95% CI)
Childhood leukemia
Prior
a 0 1.55 0.00 (0.00, 2.39) 1 1.36 0.73 (0.02, 4.08) 0.34 (0.01, 1.91)
0–4 1 1.76 0.57 (0.01, 3.17) 1 1.71 0.58 (0.01, 3.25) 0.58 (0.07, 2.08)
5–9 4 1.60 2.50 (0.68, 6.41) 1 1.57 0.64 (0.02, 3.56) 1.58 (0.51, 3.69)
10–14 2 1.49 1.34 (0.16, 4.85) 2 1.69 1.18 (0.14, 4.26) 1.26 (0.24, 3.22)
15–19 3 1.46 2.05 (0.42, 6.00) 1 1.53 0.65 (0.02, 3.64) 1.34 (0.36, 3.42)
C20 1 1.65 0.61 (0.02, 3.39) 0 1.39 0.00 (0.00, 2.64) 0.33 (0.01, 1.83)
Since start 11 7.95 1.38 (0.69, 2.47) 5 7.90 0.63 (0.21, 1.48) 1.01 (0.58, 1.64)
Childhood cancer
Prior
a 1 5.23 0.19 (0.00, 1.07) 1 4.03 0.25 (0.01, 1.38) 0.22 (0.03, 0.78)
0–4 7 5.85 1.20 (0.48, 2.46) 2 4.64 0.43 (0.05, 1.56) 0.86 (0.39, 1.63)
5–9 9 5.50 1.64 (0.75, 3.11) 4 4.74 0.84 (0.23, 2.16) 1.27 (0.68, 2.17)
10–14 7 5.60 1.25 (0.50, 2.58) 4 5.14 0.78 (0.21, 1.99) 1.02 (0.51, 1.83)
15–19 5 5.06 0.99 (0.32, 2.31) 5 4.84 1.03 (0.34, 2.41) 1.01 (0.48, 1.86)
C20 4 5.30 0.75 (0.21, 1.93) 4 4.47 0.89 (0.24, 2.29) 0.82 (0.35, 1.61)
Since start 32 27.31 1.17 (0.80, 1.65) 19 23.83 0.80 (0.48, 1.24) 1.00 (0.74, 1.31)
a For Loviisa, years 1975–77 are prior to the start of nuclear power production, and for Olkiluoto, years 1975–79
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123Table 3 Observed cancer cases (Obs) within 15-km zone, expected (Exp) cancer cases within 15–50-km zone from the NPPs and risk ratios
(RRs) with 95% conﬁdence intervals (95% CIs)
Males Females Total
Obs Exp RR 95% CI Obs Exp RR 95% CI RR 95% CI
Cohort 1980
Children
Leukemia 3 2.66 1.13 0.23, 3.30 1 1.23 0.81 0.02, 4.52 1.03 0.28, 2.63
Total cancer 11 7.60 1.45 0.72, 2.59 4 3.88 1.03 0.28, 2.64 1.31 0.73, 2.15
Adults
Leukemia 40 32.31 1.24 0.88, 1.69 25 32.37 0.77 0.50, 1.14 1.00 0.78, 1.28
Total cancer 1,524 1,554.20 0.98 0.93, 1.03 1,557 1,629.18 0.96 0.91, 1.00 0.97 0.93, 1.00
Cohort 1990
Children
Leukemia 2 1.61 1.24 0.15, 4.48 1 1.70 0.59 0.01, 3.27 0.91 0.19, 2.65
Total cancer 4 7.51 0.53 0.15, 1.36 6 5.31 1.13 0.41, 2.46 0.78 0.37, 1.43
Adults
Leukemia 14 14.24 0.98 0.54, 1.65 8 15.29 0.52 0.23, 1.03 0.74 0.47, 1.13
Total cancer 816 859.47 0.95 0.89, 1.02 860 912.17 0.94 0.88, 1.01 0.95 0.90, 0.99
Table 4 The crude odds ratios (ORs) (with 95% CI in parenthesis) of leukemia related to categorical distance measures in the municipalities
adjacent to NPPs
Children Adults
Cases Controls OR (95% CI) Cases Controls OR (95% CI)
Average distance
a
0–4 km 0 0 – 0 0 –
5–9.99 km 1 5 0.71 (0.05, 10.43) 8 27 2.08 (0.53, 8.21)
10–19.99 km 11 41 0.93 (0.20, 4.38) 75 299 1.71 (0.57, 5.10)
20–29.99 km 1 9 0.31 (0.03, 3.62) 19 66 1.98 (0.62, 6.32)
C30 km
b 3 9 1.00 4 28 1.00
p for trend 0.84 0.43
Distance at index date
0–4 km 0 0 – 0 1 0.00 (0, –)
5–9.99 km 1 5 0.46 (0.02, 12.92) 6 31 0.68 (0.21, 2.21)
10–19.99 km 12 49 0.61 (0.06, 6.04) 82 316 0.95 (0.49, 1.86)
20–29.99 km 3 10 1.00 17 64 1.00
C30 km
b 0 0 – 1 8 0.48 (0.06, 4.05)
p for trend 0.63 0.99
Minimum distance
c
0–4 km 0 0 – 0 1 0.00 (0, –)
5–9.99 km 2 6 0.91 (0.05, 17.87) 11 34 0.94 (0.33, 2.64)
10–19.99 km 11 48 0.61 (0.06, 6.04) 79 334 0.66 (0.32, 1.35)
20–29.99 km 3 10 1.00 15 44 1.00
C30 km 0 0 – 1 7 0.43 (0.05, 3.69)
p for trend 0.93 0.92
a Average distance was calculated as the sum of subject’s residential distances from the NPP weighted by their relative durations
b In the categorical analysis, maximum of average residential distances from the NPP was 172.0 km for childhood cases and 86.4 km for their
controls, and 88.5 km for adult cases and their 376.3 km controls
c Minimum distance was the shortest distance from any of the subject’s residences to the NPP
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123medians were also practically identical (15.6 km for cases
and 15.0 for controls). The maximum of average distance
was 88.5 km for adult cases and 94.3 km for their controls.
The OR for average distance for the closest 5–9.9 km
category was 2.08 (95% CI 0.53, 8.21) compared with
baseline, C30-km zone (Table 4). None of the ORs dif-
fered signiﬁcantly from unity. The OR for average distance
as continuous was 1.00 per km (95% CI 0.97, 1.03). In the
secondary analyses, for distance at index date OR was 1.01
per km (95% CI 0.96, 1.07) and for minimum distance OR
was 1.01 (95% CI 0.96, 1.07). Adjustment for history of
radiation work did not affect the ORs. ORs were compa-
rable by histological types, power plants, sexes, 15-year
age groups, or calendar time periods in the categorical or
continuous distance measures.
Of the children, more than 40% of the cases and 22% of
the controls had had three or more residencies. The num-
bers of residencies were not signiﬁcantly different between
the cases and controls in children (p = 0.20) or in adults
(p = 0.12). The OR of childhood leukemia for those with
two residencies was 2.96 (95% CI 0.32, 27.11) and for
those with three or more residencies was 13.54 (95% CI
1.10, 167.47) compared with those with only one residence.
Among adults, no such association was found.
Sensitivity analysis
Some previous studies have encompassed children aged
less than 5 years. Such approach based altogether on 8
cases and 32 controls gave an OR of 0.24 (95% CI 0.01,
5.15) for the average distance in the 5–9.9-km zone com-
pared with C30-km zone. Other studies have covered both
children and young adults aged less than 25 years and in
this case the corresponding OR was 0.44 (95% CI 0.04,
5.29) based on 20 cases with 80 matched controls.
Residential history had some missing residential coor-
dinates. An analysis restricted to subjects with complete
residential history data gave an OR of 1.29 (95% 0.05,
35.61) for the average distance in children and 2.87 (95%
CI 0.50, 16.38) in adults in the 5–9.9-km zone compared to
the C30-km zone. When all missing distances were
replaced with the minimum distance (5.5 km for children
and 2.4 km for adults), all children had average distance
less than 30 km. This approach gave an OR for average
distance in the 5–9.9-km zone of 1.35 (95% CI 0.09, 20.46)
in children and 0.63 (95% CI 0.20, 1.96) in adults com-
pared to the 20–29.9-km zone.
We included all cases diagnosed with leukemia after the
NPPs started their operation. If a one-year latency had been
used, i.e., cases during the ﬁrst year of the operations had
been omitted, one childhood leukemia case would have
been excluded, as well as four adult leukemia cases with
their controls. These exclusions had no effect on OR as the
OR for average distance in 5–9.99-km zone was 0.71 (95%
CI 0.05, 10.43) in children and 2.09 (95% CI 0.53, 8.21) in
adults compared to C30-km zone. If a two-year latency
period had been used instead, the OR for average distance
in 5–9.9-km zone would have been 1.47 (95% CI 0.06,
35.39; three cases excluded) in children and 3.04 (95% CI
0.79, 11.68; ﬁve cases excluded) in adults compared to
C30-km zone.
We assumed that the distance has a linear effect on OR
on a logit scale. We assessed this assumption by comparing
this model with those using logarithm and square root of
distance. The Akaike information criteria [14] of all
models were similar indicating no differences in ﬁt (results
not shown). We also used fractional polynomials [15], but
they did improve the ﬁt either (results not shown).
Discussion
We used three different approaches to evaluate the risk of
leukemia and overall cancer in the vicinity of the Finnish
nuclear power plants. The leukemia results were consistent
for children and did not indicate an excess of the leukemia
in the closest inhabited area (5–9.9-km zone) or a general
trend in relation to distance from the two sites. A key
limitation of our analyses was the small number of cases.
Ecological and case–control analyses included 16–17
children with leukemia. However, there was no means to
increase the number of cases as our study covered both
Finnish NPPs with their entire period of operations. Even if
the small sample size increases random error and decreases
precision, from a public health perspective, the small
number of cases is reassuring.
Similar results were obtained in ecological and cohort
analyses of other childhood cancers. There was, however,
some indication of an increased overall cancer incidence
among boys in 1981–1990 around Loviisa site. This may
well be a false-positive ﬁnding as the analyses of the
three datasets were largely explorative and covered a
number of alternative exposure metrics and signiﬁcance
tests.
Results for adults (ages 15 years and older) did not
suggest an increase in leukemia and overall cancer inci-
dence, or an association between residential distance from
a power plant and leukemia.
We were not able to assess possible effect within the 5-
km zone of the NPPs due to the small population size. The
number of permanent inhabitants within the 5-km zone of
both sites combined is approximately 100.
Ecological analysis suggests that leukemia and overall
cancer incidence in the vicinity of planned NPPs in
new sites is generally comparable to the rest of the country
both in children and adults. There was, however, some
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123indication for an increase in overall cancer incidence
among adults in the vicinity of planned NPPs in 1974–
2004.
Residential history instead of an address at one time-
point was taken into account in the cohort and case–control
data. In the cohort analysis, the zones (0–15 km and 15–
50 km) around the NPPs were deﬁned by the residence at
the end of 1980 and 1990. People may thus have moved out
from those zones thereafter, but were still included in the
data. In the case–control study, cases were deﬁned as
subjects diagnosed with leukemia with residence in the
municipalities adjacent to the NPPs. Residential history of
these cases as well as their matched controls was con-
structed since the start-up of the NPPs until the index date.
These datasets do not include children who have lived in
the vicinity of NPPs and have moved elsewhere just before
leukemia diagnosis, but this number is more likely to be
very small.
Residential history data had some missing residential
coordinates. In children, the percentages of missing resi-
dential coordinates were slightly higher in cases (8%) than
in controls (4%), whereas in adults, the corresponding
percentage was slightly higher in controls (11%) than in
cases (6%). The sensitivity analyses showed, however, that
the results and conclusions were robust to missing resi-
dential data and the assumptions made. In children, the
residential history data were complete from 1990 onwards.
Parents’ radiation work (in children) and own history of
radiation work (in adults) were taken into account in the
analyses as a surrogate for radiation exposure. More
detailed information on radiation exposure, cumulative
dose, for example, could not be used because the principles
for recording doses in the occupational exposure registry
have not been consistent during the study period. Current
practice to record all doses has been introduced gradually,
and earlier doses below a certain time-varying limit may
not have been recorded.
Clusters of childhood leukemia have been shown not
only in the vicinity of nuclear installations [16] but also in
other locations [17]. Incidence of childhood leukemia has
been increasing since the end of 1970 in the developed
countries [18]. Childhood leukemia is a multi-factorial
disease, and ionizing radiation is one of the few well-
established risk factors [19–21]. Less consistent evidence is
available for the roles of non-ionizing radiation [22], pes-
ticides [23], common infections, and population mixing
[24–26].
The number of residencies could be considered as a
surrogate for common population mixing and common
infections. Moving involves contact with new populations,
with potential being introduced to new infectious agents.
This could increase the risk of leukemia as childhood
leukemia may be a rare result of a common infection,
possibly related to age at contact or immune factors [24–
26]. The elevated risk of leukemia in children with two or
more residencies is in accordance with this hypothesis.
Further exploration of this issue in a larger material may be
worthwhile.
The mean effective dose due to ionizing radiation in
Finland is about 3.7 mSv annually [27]. Major sources of
radiation are indoor radon (2.0 mSv), medical examina-
tions (0.50 mSv), terrestrial radiation, and building mate-
rial (0.45 mSv), as well as cosmic radiation (0.33 mSv).
Actually, the existing NPPs and their surroundings differ in
this sense: Olkiluoto surroundings have lower terrestrial
background dose and the same relates also to the radon
doses in the dwellings of nearby towns compared with
Loviisa surroundings. Environmental surveillance for
radioactive releases has been conducted by STUK around
the Finnish power plants since the start of their operations.
Measurable radioactive releases have been rare [28]. The
highest mean doses to the most heavily exposed groups
living in the vicinity of Finnish NPPs were estimated in the
1980s, and they were about 1/1,000 of the annual effective
dose received from other sources [27, 28]. Currently, the
mean doses to the most heavily exposed groups are
1/10,000 or less of the mean overall effective dose from
all sources. Such low radiation doses are not expected to
cause any observable increase in leukemia or other
diseases.
This study showed no evidence of increased incidence
of childhood leukemia around Finnish nuclear power
plants. The main limitation was the small sample size
owing to small population size in the areas surrounding the
plants. Therefore, we could not meaningfully assess the
risks within a 5-km zone around the power plants or leu-
kemia at 0–4 years of age. This does not, however, detract
from the reassuring ﬁndings from the public health
perspective.
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